Celebrating the discovery of mutated CALR
MPN Research Foundation is proud to celebrate the 10-year anniversary of the identification of CALR as a common driver of MPNs. We funded early work that discovered this MPN driver mutation. Learn more >
MPNRF by the numbers
Total donated dollars
invested in research
$ 0 M
Researchers supported
0
Countries with
supported research
0
Projects funded
0

What is
essential
thrombocythemia
(ET)
?

Essential Thrombocythemia (ET)

Most commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding.

Learn more about ET

What is
polycythemia vera
(PV)
?

Polycythemia vera (PV)

The disease is most common in men over the age of 60, but anyone can develop PV. PV patients typically experience an elevated red blood cell count, an elevated platelet count and an enlarged spleen, especially over time.

Learn more about PV

What is
myelofibrosis
(MF)
?

Myelofibrosis (MF)

MF is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells.

Learn more about MF
Patients, clinicians, researchers, and the biotech and pharma industries all have critical roles to play in advancing MPN research and are all important members of the MPNRF community.
Connect with us to be part of our coordinated effort to find new treatments — and eventually cures — for MPNs.

Patients
and Caregivers

Every patient experience is unique and provides new clues for researchers and clinicians.

Researchers
and
Clinicians

In our 24-year history, MPNRF has contributed to some of the most influential MPN research discoveries.

Industry
and
Biopharma

Engage with us to ensure that new therapies have the maximum impact on patient outcomes and quality of life.

Download our Voice of the Patient report

Ready to do more?

Julie and her family joined team MPN and created HikeMF to join the fight against MPNs.

Stay connected

Invest in MPN research

Your investment supports doctors and researchers around the world who are dedicated to finding cures for MPNs.

 INVEST NOW

Join the community
Be the first to know about the latest news and advancements for ET, PV, and MF. Sign up to receive our newsletters and alerts.

Recent news

  • Trouble in the neighborhood: How one type of chromosome abnormality is more common than previously thought

    MPN NEWS | January 27, 2025

    Trouble in the neighborhood: How one type of chromosome abnormality is more common than previously thought A recent study by Dr. Vesna Najfeld and her team brings fresh insights into myelofibrosis (MF), a type of myeloproliferative neoplasm (MPN). Their work highlights the importance of closely tracking genetic changes over time and suggests that changes around… Read More »Trouble in the neighborhood: How one type of chromosome abnormality is more common than previously thought

    READ MORE

    A wedding with a cause: How Adam and Jenny transformed tradition into purpose 

    MPN NEWS | January 27, 2025

    A wedding with a cause: How Adam and Jenny transformed tradition into purpose When Jenny Applequist was diagnosed with a myeloproliferative neoplasm (MPN) in 2019, it marked the beginning of a transformative journey. “I felt a flood of emotions when I was first diagnosed,” Jenny shared. “I was still in denial for years.” Over time,… Read More »A wedding with a cause: How Adam and Jenny transformed tradition into purpose 

    READ MORE

    Dr. Anandi Krishnan, PhD Research Profile

    MPN NEWS | January 27, 2025

    Profile: Dr. Anandi Krishnan, PhDRutgers University Dr. Anandi Krishnan: A pioneer in collaborative MPN research  Dr. Anandi Krishnan, PhD, believes that meaningful scientific breakthroughs don’t happen in isolation. In an academic world where scientific discovery often feels siloed, Dr. Anandi Krishnan’s new laboratory in the department of biomedical engineering at Rutgers University operates like a bustling… Read More »Dr. Anandi Krishnan, PhD Research Profile

    READ MORE